The study revealed a lower risk of nephrolithiasis with SGLT2 inhibitors than DPP4 inhibitors in both stone never-formers and ...

A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of cardiovascular disease.

SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.

SGLT-2 inhibitors, compared with DPP-4 inhibitors, were associated with a lower risk for liver cirrhosis among patients with type 2 diabetes. Sodium-glucose cotransporter 2 (SGLT-2) inhibitors ...

NEWSCENTER 5. ALL RIGHT, SARA, THANK YOU. FOR THE SECOND TIME, MASS GENERAL HAS TRANSPLANTED A KIDNEY FROM A PIG TO A PERSON. IT’S JUST THE FOURTH TIME THIS PROCEDURE HAS BEEN DONE ANYWHERE IN ...

And hopefully, we can get to survival, kidney survival, for over two years.” 5 Tim Andrews (right), 66, is only the second person known to be living with a pig kidney.

A New Hampshire man fought for the chance at a pig kidney transplant, spending months getting into good enough shape to be part of a small pilot study of a highly experimental treatment.

ft. distribution facility for its walk-in units in Temple. British maker of solar- and battery-powered transport refrigeration units expands production at its Leatherhead, Surrey, headquarters ...

Uncontrolled blood glucose (sugar) can lead to complications that may include cardiovascular disease, high blood pressure, nerve and eye damage, and kidney disease. Now, an analysis of studies has ...

GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...

Please provide your email address to receive an email when new articles are posted on . Overall, 44% of the calorie restriction and dapaglifozin treatment group achieved diabetes remission ...

Several risk tools can accurately predict individual baseline risks of adverse events in people with chronic kidney disease. Here, the authors examine methods of assessing risk and discuss risk ...